Rationale and Design of a Randomized, Open‐Label, Parallel‐Group Study of Esaxerenone Versus Angiotensin Receptor Blockers in Older Patients With Uncontrolled Hypertension on Calcium Channel Blocker Monotherapy (ESCORT‐HT)

Ähnliche Einträge

• Antihypertensive effect of esaxerenone and correlation between brachial and wrist home monitoring devices in patients with nocturnal hypertension: A post hoc analysis of the EARLY‐NH study
  von: Kazuomi Kario, et al.
  Veröffentlicht: (2024)
• Letter to the Editor: “Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients With Hypertension Combined Prediabetes”
  von: Sabika Ayesha, et al.
  Veröffentlicht: (2025)
• A Letter to the Editor on “Reducing the Risk of Developing Diabetes: The Role of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors in Patients with Hypertension Combined Prediabetes”
  von: Ghaniya Khan
  Veröffentlicht: (2025)
• Efficacy and Safety of Sacubitril/Valsartan Versus Amlodipine in Japanese Patients With Essential Hypertension: A Randomized, Multicenter, Open‐Label, Noninferiority Study (PARASOL Study)
  von: Koichi Yamamoto, et al.
  Veröffentlicht: (2024)
• Precise risk‐prediction model including arterial stiffness for new‐onset atrial fibrillation using machine learning techniques
  von: Hiroshi Kanegae, et al.
  Veröffentlicht: (2024)